Surgical revascularization of myocardium in population of young women. Is it a group of increased operative risk?

Archives of Medical Science

Volumn 5, Issue 2, 2009, Pages 135-140

  Dziuba, Michal ^a   Jander, Slawomir ^a   Zwolinski, Radoslaw ^a   Chizynski, Krzysztof ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Coronary artery bypass grafting; Ischaemic heart disease; Premenopausal women

Indexed keywords

ESTROGEN RECEPTOR;

ATHEROMATOSIS; CEREBROVASCULAR ACCIDENT; COMA; CORONARY ARTERY BYPASS GRAFT; FEMALE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HIGH RISK PATIENT; HUMAN; ISCHEMIC HEART DISEASE; MORBIDITY; POSTOPERATIVE PERIOD; PREMENOPAUSE; PROGNOSIS; PROTEIN EXPRESSION; REVIEW; SEX DIFFERENCE; SURGICAL MORTALITY; SURVIVAL; TRANSIENT ISCHEMIC ATTACK;

EID: 70349656647     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. American Heart Association. Women and cardiovascular diseases. Available at: http://www.americanheart.org/presenter.jhtml?identifier=2011.
2. Meinert CL, Gilpin AK, Unalp A, et al. Gender representation in trials. Control Clin Trials 2000; 21: 462-75.
3. Enas AE. Lipoprotein (a) as a determinant of coronary heart disease in young women: a stronger risk factor than diabetes? Circulation 1998; 97: 293-5.
4. O'Rourke DJ, Malenka DJ, Olmstead EM, et al. Improved in-hospital mortality in women undergoing coronary artery bypass grafting. Northern New England Cardiovascular Disease Study Group. Ann Thorac Surg 2001; 71: 507-11.
5. Elsaesser A, Hamm CW. Acute coronary syndrome: the risk of being female. Circulation 2004; 109: 565-7.
6. Castelli WP. Epidemiology of coronary heart disease: the Framingham Study. Am J Med 1984; 76: 4-13.
7. Vaccarino V, Parsons L, Every NR, Barron HV, Krumholz HM. Sex-based differences in early mortality after myocardial infarction. 2 Participants. N Engl J Med 1999; 341: 217-25.
8. Vaccarino V, Krumholz HM, Varzebski J, et al. Sex differences in 2-year mortality after hospital discharge for myocardial infarction. Ann Intern Med 2001; 134: 173-81.
9. Vaccarino V, Abramson JL, Veledar E, Weintraub WS. Sex differences in hospital mortality after coronary artery bypass surgery. Evidence for a higher mortality in younger women. Circulation 2002; 105: 1176-81.
10. Regitz-Zagrosek V, Lehmkuhl E, Hocher B, et al. Gender as a risk factor, not in old, women undergoing coronary artery bypass grafting. J Am Coll Cardiol 2004; 44: 2413-4.
11. Gardner TJ, Horneffer PJ, Gott VL, et al. Coronary artery bypass grafting in women: a ten-year perspective. Ann Surg 1985; 201: 780-4.
12. Hogue CW Jr, Barzilai B, Pieper KS, et al. Sex differences in neurological outcomes and mortality after cardiac surgery. A Society of Thoracic Surgery National Database report. Circulation 2001; 103: 2133-7.
13. Herlitz J, Brandrup-Wognsen G, Karlson BW, et al. Mortality, risk indicators of death, mode of death and symptoms of angina pectoris during 5 years after coronary artery bypass grafting in men and women. J Intern Med 2000; 247: 500-6.
14. Humphries KH, Gao M, Pu A, Lichtenstein S, Thompson CR. Significant improvement in short-term mortality in women undergoing coronary artery bypass surgery (1991 to 2004). J Am Coll Cardiol 2007; 49: 1552-8.
15. Zwoliński R, Jander S, Jegier B, et al. Obraz kliniczny i powikłania okołooperacyjne u chorych poddanych chirurgicznej rewaskularyzacji mieśnia sercowego do 45 roku życia [Polish]. Pol J Cardiol 2002; 4: 349-54.
16. Vaccarino V, Lin Qiu Z, Kasl SV. Gender differences in recovery after coronary artery bypass surgery. J Am Coll Cardiol 2003; 41: 307-14.
17. Sheifer SE, Escarce JJ, Schulman KA. Race and sex differences in the management of coronary artery disease. Am Heart J 2000; 139: 848-57.
18. Weintraub WS, Kosinski AS, Wenger NK. Is there a bias performing coronary revascularization in women? Am J Cardiol 1996; 78: 1154-60.
19. Di Carli MF, Afonso L, Campisi R, et al. Coronary vascular dysfunction in premenopausal women with diabetes mellitus. Am Heart J 2002; 144: 711-8.
20. Steinberg HO, Paradisi G, Cronin J, et al. Type II abrogates sex differences in endothelial function in premenopausal women. Circulation 2000; 101: 2040-6.
21. Słowińska-Srzednicka J, Malczewska B, Srzednicki M, et al. Hyperinsulinaemia and decreased plasma levels of dehydroepiandrosterone sulfate in premenopausal women with coronary heart disease. J Intern Med 1995; 237: 465-72.
22. Croft P, Hannaford PC. Risk factors for acute myocardial infarction: evidence from the Royal College of General Practitioners' oral contraception study. BMJ 1989; 298: 165-8.
23. Hu FB, Grodstein F, Hennekens CH, et al. Age at natural menopause and risk of cardiovascular disease. Arch Intern Med 1999; 159: 1061-6.
24. Burke AP, Farb A, Malcolm GT, et al. Effect of risk factors on the mechanism of acute thrombosis and sudden coronary death in women. Circulation 1998; 97: 2110-6.
25. Ramström J, Lund O, Cadavid E, Thuren J, Oxelbark S, Henze A. Multiarterial coronary artery bypass grafting with special reference to small vessel disease and results in women. Eur Heart J 1993; 14: 634-9.
26. Nishida H, Nakajima M, Ihashi K, et al. Effects of smaller physical size on complex arterial grafting in coronary artery operations. Ann Thorac Surg 1996; 62: 733-6.
27. Loop FD, Golding LR, MacMillan JP, Cosgrove DM, Lytle BW, Sheldon WC. Coronary artery surgery in women compared with men: analyses of risks and long-term results. J Am Coll Cardiol 1983; 1: 383-90.
28. Sheifer SE, Canos MR, Weinfurt KP, et al. Sex differences in coronary artery size assessed by intravascular ultrasound. Am Heart J 2000; 139: 649-53.
29. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999; 340: 1801-11.
30. Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH. Menopause and risk of coronary heart disease in women. N Engl J Med 1987; 316: 1105-10.
31. Losordo DW, Kearney M, Kim EA, Jekanowski J, Isner JM. Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation 1994; 89: 1501-10.
32. Kortelainen ML, Huttunen P. Expression of estrogen receptors in the coronary arteries of young and premenopausal women in relation to central obesity. Int J Obes Relat Metab Disord 2004; 28: 623-7.
33. Shearman AM, Cupples LA, Demissie S, et al. Association between estrogen alpha gene variation and cardiovascular disease. JAMA 2003; 290: 2263-70.
34. Carmina E, Lobo RA. Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women. J Clin Endocrinol Metab 1999; 84: 1897-9.
35. Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 1999; 22: 141-6.
36. Dahlgren E, Janson PO, Johansson S, Lapidus L, Odén A. Polycystic ovary syndrome and risk for myocardial infarction: evaluated from a risk factor model based on a prospective population study of women. Acta Obstet Gynecol Scand 1992; 71: 599-604.
37. Orth-Gomer K, Mittleman MA, Schenck-Gustafsson K, et al. Lipoprotein (a) as a determinant of coronary heart disease in young women. Circulation 1997; 95: 329-34.